IoT Automotive
IoT Automotive market is segmented by players, region (country), by Type and by Application. Play ... Read More
Global In-Vitro Diagnostic Market Research Report 2023
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Diagnostic Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Test Equipment
1.2.3 Test Reagents
1.3 Market by Application
1.3.1 Global In-Vitro Diagnostic Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals and Clinics
1.3.3 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Diagnostic Market Perspective (2017-2028)
2.2 In-Vitro Diagnostic Growth Trends by Region
2.2.1 In-Vitro Diagnostic Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 In-Vitro Diagnostic Historic Market Size by Region (2017-2022)
2.2.3 In-Vitro Diagnostic Forecasted Market Size by Region (2023-2028)
2.3 In-Vitro Diagnostic Market Dynamics
2.3.1 In-Vitro Diagnostic Industry Trends
2.3.2 In-Vitro Diagnostic Market Drivers
2.3.3 In-Vitro Diagnostic Market Challenges
2.3.4 In-Vitro Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Diagnostic Players by Revenue
3.1.1 Global Top In-Vitro Diagnostic Players by Revenue (2017-2022)
3.1.2 Global In-Vitro Diagnostic Revenue Market Share by Players (2017-2022)
3.2 Global In-Vitro Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Diagnostic Revenue
3.4 Global In-Vitro Diagnostic Market Concentration Ratio
3.4.1 Global In-Vitro Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Diagnostic Revenue in 2021
3.5 In-Vitro Diagnostic Key Players Head office and Area Served
3.6 Key Players In-Vitro Diagnostic Product Solution and Service
3.7 Date of Enter into In-Vitro Diagnostic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Diagnostic Breakdown Data by Type
4.1 Global In-Vitro Diagnostic Historic Market Size by Type (2017-2022)
4.2 Global In-Vitro Diagnostic Forecasted Market Size by Type (2023-2028)
5 In-Vitro Diagnostic Breakdown Data by Application
5.1 Global In-Vitro Diagnostic Historic Market Size by Application (2017-2022)
5.2 Global In-Vitro Diagnostic Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America In-Vitro Diagnostic Market Size (2017-2028)
6.2 North America In-Vitro Diagnostic Market Size by Country (2017-2022)
6.3 North America In-Vitro Diagnostic Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe In-Vitro Diagnostic Market Size (2017-2028)
7.2 Europe In-Vitro Diagnostic Market Size by Country (2017-2022)
7.3 Europe In-Vitro Diagnostic Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Diagnostic Market Size (2017-2028)
8.2 Asia-Pacific In-Vitro Diagnostic Market Size by Country (2017-2022)
8.3 Asia-Pacific In-Vitro Diagnostic Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America In-Vitro Diagnostic Market Size (2017-2028)
9.2 Latin America In-Vitro Diagnostic Market Size by Country (2017-2022)
9.3 Latin America In-Vitro Diagnostic Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Diagnostic Market Size (2017-2028)
10.2 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2017-2022)
10.3 Middle East & Africa In-Vitro Diagnostic Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott In-Vitro Diagnostic Introduction
11.1.4 Abbott Revenue in In-Vitro Diagnostic Business (2017-2022)
11.1.5 Abbott Recent Development
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Detail
11.2.2 Johnson and Johnson Business Overview
11.2.3 Johnson and Johnson In-Vitro Diagnostic Introduction
11.2.4 Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2017-2022)
11.2.5 Johnson and Johnson Recent Development
11.3 BD
11.3.1 BD Company Detail
11.3.2 BD Business Overview
11.3.3 BD In-Vitro Diagnostic Introduction
11.3.4 BD Revenue in In-Vitro Diagnostic Business (2017-2022)
11.3.5 BD Recent Development
11.4 Danaher
11.4.1 Danaher Company Detail
11.4.2 Danaher Business Overview
11.4.3 Danaher In-Vitro Diagnostic Introduction
11.4.4 Danaher Revenue in In-Vitro Diagnostic Business (2017-2022)
11.4.5 Danaher Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In-Vitro Diagnostic Introduction
11.5.4 Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2017-2022)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Bio-Rad
11.6.1 Bio-Rad Company Detail
11.6.2 Bio-Rad Business Overview
11.6.3 Bio-Rad In-Vitro Diagnostic Introduction
11.6.4 Bio-Rad Revenue in In-Vitro Diagnostic Business (2017-2022)
11.6.5 Bio-Rad Recent Development
11.7 Hologic
11.7.1 Hologic Company Detail
11.7.2 Hologic Business Overview
11.7.3 Hologic In-Vitro Diagnostic Introduction
11.7.4 Hologic Revenue in In-Vitro Diagnostic Business (2017-2022)
11.7.5 Hologic Recent Development
11.8 KEM-EN-TEC Diagnostics
11.8.1 KEM-EN-TEC Diagnostics Company Detail
11.8.2 KEM-EN-TEC Diagnostics Business Overview
11.8.3 KEM-EN-TEC Diagnostics In-Vitro Diagnostic Introduction
11.8.4 KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022)
11.8.5 KEM-EN-TEC Diagnostics Recent Development
11.9 Medtronic
11.9.1 Medtronic Company Detail
11.9.2 Medtronic Business Overview
11.9.3 Medtronic In-Vitro Diagnostic Introduction
11.9.4 Medtronic Revenue in In-Vitro Diagnostic Business (2017-2022)
11.9.5 Medtronic Recent Development
11.10 Omega Diagnostics
11.10.1 Omega Diagnostics Company Detail
11.10.2 Omega Diagnostics Business Overview
11.10.3 Omega Diagnostics In-Vitro Diagnostic Introduction
11.10.4 Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022)
11.10.5 Omega Diagnostics Recent Development
11.11 Ortho Clinical Diagnostics
11.11.1 Ortho Clinical Diagnostics Company Detail
11.11.2 Ortho Clinical Diagnostics Business Overview
11.11.3 Ortho Clinical Diagnostics In-Vitro Diagnostic Introduction
11.11.4 Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022)
11.11.5 Ortho Clinical Diagnostics Recent Development
11.12 Roche
11.12.1 Roche Company Detail
11.12.2 Roche Business Overview
11.12.3 Roche In-Vitro Diagnostic Introduction
11.12.4 Roche Revenue in In-Vitro Diagnostic Business (2017-2022)
11.12.5 Roche Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Detail
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers In-Vitro Diagnostic Introduction
11.13.4 Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2017-2022)
11.13.5 Siemens Healthineers Recent Development
11.14 Sysmex
11.14.1 Sysmex Company Detail
11.14.2 Sysmex Business Overview
11.14.3 Sysmex In-Vitro Diagnostic Introduction
11.14.4 Sysmex Revenue in In-Vitro Diagnostic Business (2017-2022)
11.14.5 Sysmex Recent Development
11.15 Atlas Genetics
11.15.1 Atlas Genetics Company Detail
11.15.2 Atlas Genetics Business Overview
11.15.3 Atlas Genetics In-Vitro Diagnostic Introduction
11.15.4 Atlas Genetics Revenue in In-Vitro Diagnostic Business (2017-2022)
11.15.5 Atlas Genetics Recent Development
11.16 ELITechGroup
11.16.1 ELITechGroup Company Detail
11.16.2 ELITechGroup Business Overview
11.16.3 ELITechGroup In-Vitro Diagnostic Introduction
11.16.4 ELITechGroup Revenue in In-Vitro Diagnostic Business (2017-2022)
11.16.5 ELITechGroup Recent Development
11.17 Biomerieux
11.17.1 Biomerieux Company Detail
11.17.2 Biomerieux Business Overview
11.17.3 Biomerieux In-Vitro Diagnostic Introduction
11.17.4 Biomerieux Revenue in In-Vitro Diagnostic Business (2017-2022)
11.17.5 Biomerieux Recent Development
11.18 Werfen
11.18.1 Werfen Company Detail
11.18.2 Werfen Business Overview
11.18.3 Werfen In-Vitro Diagnostic Introduction
11.18.4 Werfen Revenue in In-Vitro Diagnostic Business (2017-2022)
11.18.5 Werfen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global In-Vitro Diagnostic Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Test Equipment
Table 3. Key Players of Test Reagents
Table 4. Global In-Vitro Diagnostic Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 5. Global In-Vitro Diagnostic Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global In-Vitro Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global In-Vitro Diagnostic Market Share by Region (2017-2022)
Table 8. Global In-Vitro Diagnostic Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global In-Vitro Diagnostic Market Share by Region (2023-2028)
Table 10. In-Vitro Diagnostic Market Trends
Table 11. In-Vitro Diagnostic Market Drivers
Table 12. In-Vitro Diagnostic Market Challenges
Table 13. In-Vitro Diagnostic Market Restraints
Table 14. Global In-Vitro Diagnostic Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global In-Vitro Diagnostic Market Share by Players (2017-2022)
Table 16. Global Top In-Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostic as of 2021)
Table 17. Ranking of Global Top In-Vitro Diagnostic Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by In-Vitro Diagnostic Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-Vitro Diagnostic Product Solution and Service
Table 21. Date of Enter into In-Vitro Diagnostic Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Diagnostic Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global In-Vitro Diagnostic Revenue Market Share by Type (2017-2022)
Table 25. Global In-Vitro Diagnostic Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global In-Vitro Diagnostic Revenue Market Share by Type (2023-2028)
Table 27. Global In-Vitro Diagnostic Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global In-Vitro Diagnostic Revenue Market Share by Application (2017-2022)
Table 29. Global In-Vitro Diagnostic Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global In-Vitro Diagnostic Revenue Market Share by Application (2023-2028)
Table 31. North America In-Vitro Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 32. North America In-Vitro Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 33. Europe In-Vitro Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 34. Europe In-Vitro Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 35. Asia-Pacific In-Vitro Diagnostic Market Size by Region (2017-2022) & (US$ Million)
Table 36. Asia-Pacific In-Vitro Diagnostic Market Size by Region (2023-2028) & (US$ Million)
Table 37. Latin America In-Vitro Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 38. Latin America In-Vitro Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 39. Middle East & Africa In-Vitro Diagnostic Market Size by Country (2017-2022) & (US$ Million)
Table 40. Middle East & Africa In-Vitro Diagnostic Market Size by Country (2023-2028) & (US$ Million)
Table 41. Abbott Company Detail
Table 42. Abbott Business Overview
Table 43. Abbott In-Vitro Diagnostic Product
Table 44. Abbott Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 45. Abbott Recent Development
Table 46. Johnson and Johnson Company Detail
Table 47. Johnson and Johnson Business Overview
Table 48. Johnson and Johnson In-Vitro Diagnostic Product
Table 49. Johnson and Johnson Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 50. Johnson and Johnson Recent Development
Table 51. BD Company Detail
Table 52. BD Business Overview
Table 53. BD In-Vitro Diagnostic Product
Table 54. BD Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 55. BD Recent Development
Table 56. Danaher Company Detail
Table 57. Danaher Business Overview
Table 58. Danaher In-Vitro Diagnostic Product
Table 59. Danaher Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 60. Danaher Recent Development
Table 61. Thermo Fisher Scientific Company Detail
Table 62. Thermo Fisher Scientific Business Overview
Table 63. Thermo Fisher Scientific In-Vitro Diagnostic Product
Table 64. Thermo Fisher Scientific Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 65. Thermo Fisher Scientific Recent Development
Table 66. Bio-Rad Company Detail
Table 67. Bio-Rad Business Overview
Table 68. Bio-Rad In-Vitro Diagnostic Product
Table 69. Bio-Rad Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 70. Bio-Rad Recent Development
Table 71. Hologic Company Detail
Table 72. Hologic Business Overview
Table 73. Hologic In-Vitro Diagnostic Product
Table 74. Hologic Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 75. Hologic Recent Development
Table 76. KEM-EN-TEC Diagnostics Company Detail
Table 77. KEM-EN-TEC Diagnostics Business Overview
Table 78. KEM-EN-TEC Diagnostics In-Vitro Diagnostic Product
Table 79. KEM-EN-TEC Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 80. KEM-EN-TEC Diagnostics Recent Development
Table 81. Medtronic Company Detail
Table 82. Medtronic Business Overview
Table 83. Medtronic In-Vitro Diagnostic Product
Table 84. Medtronic Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 85. Medtronic Recent Development
Table 86. Omega Diagnostics Company Detail
Table 87. Omega Diagnostics Business Overview
Table 88. Omega Diagnostics In-Vitro Diagnostic Product
Table 89. Omega Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 90. Omega Diagnostics Recent Development
Table 91. Ortho Clinical Diagnostics Company Detail
Table 92. Ortho Clinical Diagnostics Business Overview
Table 93. Ortho Clinical Diagnostics In-Vitro DiagnosticProduct
Table 94. Ortho Clinical Diagnostics Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 95. Ortho Clinical Diagnostics Recent Development
Table 96. Roche Company Detail
Table 97. Roche Business Overview
Table 98. Roche In-Vitro DiagnosticProduct
Table 99. Roche Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Siemens Healthineers Company Detail
Table 102. Siemens Healthineers Business Overview
Table 103. Siemens Healthineers In-Vitro DiagnosticProduct
Table 104. Siemens Healthineers Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 105. Siemens Healthineers Recent Development
Table 106. Sysmex Company Detail
Table 107. Sysmex Business Overview
Table 108. Sysmex In-Vitro DiagnosticProduct
Table 109. Sysmex Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 110. Sysmex Recent Development
Table 111. Atlas Genetics Company Detail
Table 112. Atlas Genetics Business Overview
Table 113. Atlas Genetics In-Vitro DiagnosticProduct
Table 114. Atlas Genetics Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 115. Atlas Genetics Recent Development
Table 116. ELITechGroup Company Detail
Table 117. ELITechGroup Business Overview
Table 118. ELITechGroup In-Vitro DiagnosticProduct
Table 119. ELITechGroup Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 120. ELITechGroup Recent Development
Table 121. Biomerieux Company Detail
Table 122. Biomerieux Business Overview
Table 123. Biomerieux In-Vitro DiagnosticProduct
Table 124. Biomerieux Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 125. Biomerieux Recent Development
Table 126. Werfen Company Detail
Table 127. Werfen Business Overview
Table 128. Werfen In-Vitro DiagnosticProduct
Table 129. Werfen Revenue in In-Vitro Diagnostic Business (2017-2022) & (US$ Million)
Table 130. Werfen Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Diagnostic Market Share by Type: 2021 VS 2028
Figure 2. Test Equipment Features
Figure 3. Test Reagents Features
Figure 4. Global In-Vitro Diagnostic Market Share by Application in 2021 & 2028
Figure 5. Hospitals and Clinics Case Studies
Figure 6. Diagnostic Center Case Studies
Figure 7. In-Vitro Diagnostic Report Years Considered
Figure 8. Global In-Vitro Diagnostic Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global In-Vitro Diagnostic Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global In-Vitro Diagnostic Market Share by Region: 2021 VS 2028
Figure 11. Global In-Vitro Diagnostic Market Share by Players in 2021
Figure 12. Global Top In-Vitro Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Diagnostic as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by In-Vitro Diagnostic Revenue in 2021
Figure 14. North America In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 15. North America In-Vitro Diagnostic Market Share by Country (2017-2028)
Figure 16. United States In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. Canada In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 18. Europe In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Europe In-Vitro Diagnostic Market Share by Country (2017-2028)
Figure 20. Germany In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. France In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. U.K. In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Italy In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Russia In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Nordic Countries In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Asia-Pacific In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific In-Vitro Diagnostic Market Share by Region (2017-2028)
Figure 28. China In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Japan In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. South Korea In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Southeast Asia In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. India In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Australia In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Latin America In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Latin America In-Vitro Diagnostic Market Share by Country (2017-2028)
Figure 36. Mexico In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Brazil In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Middle East & Africa In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Middle East & Africa In-Vitro Diagnostic Market Share by Country (2017-2028)
Figure 40. Turkey In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Saudi Arabia In-Vitro Diagnostic Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Abbott Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 43. Johnson and Johnson Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 44. BD Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 45. Danaher Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 47. Bio-Rad Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 48. Hologic Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 49. KEM-EN-TEC Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 50. Medtronic Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 51. Omega Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 52. Ortho Clinical Diagnostics Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 53. Roche Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 54. Siemens Healthineers Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 55. Sysmex Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 56. Atlas Genetics Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 57. ELITechGroup Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 58. Biomerieux Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 59. Werfen Revenue Growth Rate in In-Vitro Diagnostic Business (2017-2022)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Johnson and Johnson BD Danaher Thermo Fisher Scientific Bio-Rad Hologic KEM-EN-TEC Diagnostics Medtronic Omega Diagnostics Ortho Clinical Diagnostics Roche Siemens Healthineers Sysmex Atlas Genetics ELITechGroup Biomerieux Werfen